55.81
1.15%
-0.65
Dopo l'orario di chiusura:
55.69
-0.12
-0.22%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$56.46
Aprire:
$56.74
Volume 24 ore:
10.28M
Relative Volume:
1.07
Capitalizzazione di mercato:
$72.42B
Reddito:
$363.25B
Utile/perdita netta:
$7.19B
Rapporto P/E:
8.4178
EPS:
6.63
Flusso di cassa netto:
$5.27B
1 W Prestazione:
-1.20%
1M Prestazione:
-9.31%
6M Prestazione:
-0.89%
1 anno Prestazione:
-18.80%
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
2024-05-30 | Iniziato | Robert W. Baird | Neutral |
2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
2024-05-02 | Downgrade | UBS | Buy → Neutral |
2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
2024-03-06 | Iniziato | Barclays | Equal Weight |
2024-02-26 | Iniziato | Leerink Partners | Outperform |
2023-12-22 | Iniziato | HSBC Securities | Buy |
2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
2023-05-26 | Iniziato | Piper Sandler | Overweight |
2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
2022-11-23 | Ripresa | Morgan Stanley | Overweight |
2022-06-17 | Iniziato | Loop Capital | Buy |
2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
2021-12-14 | Iniziato | Goldman | Buy |
2021-12-01 | Iniziato | Seaport Research Partners | Buy |
2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
2020-09-17 | Iniziato | Piper Sandler | Overweight |
2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
2019-09-12 | Iniziato | Deutsche Bank | Buy |
2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
2019-04-18 | Iniziato | Guggenheim | Buy |
2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
2019-04-10 | Reiterato | BofA/Merrill | Buy |
2019-03-13 | Iniziato | Bernstein | Outperform |
2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
2019-01-17 | Iniziato | UBS | Buy |
2018-12-18 | Iniziato | Barclays | Overweight |
2018-11-29 | Ripresa | Goldman | Neutral |
2018-11-28 | Iniziato | Evercore ISI | Outperform |
2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
2018-02-27 | Ripresa | BofA/Merrill | Buy |
2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
US Bancorp DE Cuts Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS faces credit rating review as debt leverage climbs - The Business Journals
CVS Health Stock: Analyst Estimates & Ratings - Barchart
Willow Grove man charged with insider trading after making $617K on CVS Health deal - Glenside Local
Curious about CVS Health (CVS) Q3 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance
Willow Grove man faces insider trading charges after CVS-Oak Street deal - The Philadelphia Inquirer
CVS Unit Exec's Ex-Partner Charged With Insider Trading - Law360
Scientist Charged With Trading on Domestic Partner’s Deal Secret - Bloomberg
SEC Sues Scientist for Insider Trading in CVS-Oak Street Merger - Bloomberg Law
Pennsylvania man charged with insider trading related to CVS takeover - MSN
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
Pennsylvania man charged with insider trading related to CVS takeover By Reuters - Investing.com
CVS Credit Rating at Risk After Growth Gamble Fails to Pay Off - Bloomberg
CVS Health Corporation (CVS): Among The 10 Oversold Blue Chip Stocks to Buy Now - Insider Monkey
CVS Health Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
10 Oversold Blue Chip Stocks to Buy Now - Insider Monkey
Earnings Preview: CVS Health (CVS) Q3 Earnings Expected to Decline - Yahoo Finance
CVS Health Insider Lowered Holding By 40% During Last Year - Yahoo Finance
CVS Health (CVS) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
CVS Health (CVS) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
CVS Health Corporation (CVS): Is This High Growth Retail Stock Profitable in 2024? - Insider Monkey
Mirae Asset Global Investments Co. Ltd. Sells 8,763 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) the Most Profitable Value Stock To Invest In? - Insider Monkey
CVS needs ‘realistic targets’ it can exceed says analyst after CEO dismissal - Yahoo Finance
CVS appoints new CEO amid restructuring - The Ticker
DekaBank Deutsche Girozentrale Has $113.86 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS CEO Exit Ends Promising Era of Women Heading Pharmacy Chains - MSN
CVS Caremark To Report Q4 Results: Earnings Preview - RTTNews
CVS Caremark Q4 Profit Slightly Down; Adj. EPS Tops ViewUpdate - RTTNews
CVS Caremark Q3 Profit Rises; Lifts FY11 EPS ViewUpdate - RTTNews
CVS Caremark Operating Chief Merlo To Become CEO In March - RTTNews
CVS Caremark Q4 Results Tops Estimates, Lifts 2013 Outlook - RTTNews
CVS names Joyner as CEO under investor pressure, withdraws profit forecast - MSN
International Assets Investment Management LLC Buys 1,133,184 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Health insurers unveil Medicare Advantage plans for 2025 - MSN
More US firms lean on retired, veteran leaders to steady ship in choppy economy - MSN
Inside CVS and Walgreens' downturn: How misguided M&A damaged America's drugstores - Fortune
CVS Health Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
How misguided M&A damaged America’s drugstores - Yahoo Finance
CVS Health Co. (NYSE:CVS) Shares Purchased by Cullinan Associates Inc. - MarketBeat
Analysis-Can the new CVS CEO handle the Aetna challenge? - MSN
CVS shows women are hired to do impossible jobs - Victoria Advocate
CVS Health Corp. stock underperforms Thursday when compared to competitors - MarketWatch
SoCal Union Workers, CVS Reach Tentative Agreement - Progressive Grocer
CVS Q3 Estimates Plunge Before Earnings Release: How to Play the Stock - Yahoo Finance
CVS Health Stock Dip: Undervalued And Ready For A Turnaround (NYSE:CVS) - Seeking Alpha
A new CVS partnership supports coordinated health care, free Uber rides to appointments - The Atlanta Journal Constitution
Mizuho cuts CVS Health stock price target, keeps Outperform rating - Investing.com
Is CVS Health (NYSE:CVS) Using Too Much Debt? - Yahoo Finance
SOL Capital Management CO Acquires 9,075 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cvs Health Corp Azioni (CVS) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Mahoney Michael F | Director |
May 02 '24 |
Buy |
54.49 |
9,181 |
500,294 |
9,356 |
Shah Prem S | EVP and Pres-Pharm, Consumer W |
Feb 16 '24 |
Sale |
76.95 |
29,473 |
2,267,947 |
39,765 |
LUDWIG EDWARD J | Director |
Nov 03 '23 |
Buy |
70.47 |
2,000 |
140,930 |
20,630 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):